Related Experiment Video
Updated: Feb 23, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Non-small cell lung cancer: miR-30d suppresses tumor invasion and migration by directly targeting NFIB
Yubing Wu1, Jingnan Zhang2, Shizhen Hou1
1Department of Thoracic Surgery, Linyi Central Hospital of Shandong, Jiankang Road No. 17, Linyi, 276400, People's Republic of China.
Objective:
To evaluate the role and the molecular mechanism of miR-30d in non-small cell lung cancer (NSCLC).
Results:
qRT-PCR was used to detect miR-30d expression in NSCLC tissues and cell lines. miR-30d was frequently down-regulated in NSCLC and its expression was associated with clinicopathological features of NSCLCC patients. Over-expression of miR-30d notably inhibited cell migration and invasion in NSCLC cell lines. miR-30d could negatively regulate Nuclear factor I B (NFIB) by directly targeting its 3'-UTR, which was confirmed by luciferase assay. NFIB also reversed miR-30d-mediated suppression on the migration and invasion in NSCLC cell lines.
Conclusion:
miR-30d suppressed cell migration and invasion by directly targeting NFIB in NSCLC, and NFIB could partially abrogated the inhibition of biological functions by miR-30d.
Insights
MicroRNA-30d (miR-30d) is downregulated in non-small cell lung cancer (NSCLC). It suppresses tumor cell migration and invasion by targeting Nuclear factor I B (NFIB).
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Non-small cell lung cancer (NSCLC) is a major cause of cancer-related mortality.
- The role of microRNAs (miRNAs) in NSCLC pathogenesis is an active area of research.
- Understanding the molecular mechanisms underlying NSCLC progression is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the function of miR-30d in non-small cell lung cancer (NSCLC).
- To elucidate the molecular mechanism by which miR-30d influences NSCLC progression.
Main Methods:
- Quantitative reverse transcription polymerase chain reaction (qRT-PCR) to assess miR-30d expression levels.
- Cell migration and invasion assays in NSCLC cell lines.
- Luciferase reporter assay to validate direct targeting of Nuclear factor I B (NFIB) by miR-30d.
- Overexpression studies of miR-30d and NFIB in NSCLC cell lines.
Main Results:
- miR-30d was frequently downregulated in NSCLC tissues and cell lines.
- Downregulation of miR-30d correlated with specific clinicopathological features in NSCLC patients.
- Overexpression of miR-30d significantly inhibited cell migration and invasion in NSCLC.
- miR-30d directly targets the 3'-untranslated region (3'-UTR) of Nuclear factor I B (NFIB) mRNA.
- NFIB overexpression partially reversed the inhibitory effects of miR-30d on cell migration and invasion.
Conclusions:
- miR-30d acts as a tumor suppressor in NSCLC by inhibiting cell migration and invasion.
- The mechanism involves direct targeting of Nuclear factor I B (NFIB) by miR-30d.
- NFIB partially counteracts the tumor-suppressive functions of miR-30d in NSCLC.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
MicroRNAs

